An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
CONCLUSION: A practical approach to investigating patients with persistent thrombocytosis based on clinical characteristics such as active malignancy, chronic inflammatory disease, splenectomy, and iron deficiency may assist in accurately identifying patients more likely to have secondary causes of thrombocytosis and reduce overinvestigation, particularly costly molecular testing.PMID:38375212 | PMC:PMC10876298 | DOI:10.1155/2024/3056216 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Ala Almanaseer Benjamin Chin-Yee Jenny Ho Alejandro Lazo-Langner Laila Schenkel Pratibha Bhai Bekim Sadikovic Ian H Chin-Yee Cyrus C Hsia Source Type: research
Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review
CONCLUSIONS: MM in KNH is a disease of the middle aged, affecting men and women almost equally and presenting mainly with bone pain and anaemia. Although there seems to be a general improvement in diagnosis and care, access to novel and less toxic agents for treatment is still wanting.PMID:38375211 | PMC:PMC10876299 | DOI:10.1155/2024/3208717 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Wanjiku Gichuru Nicholas A O Abinya Andrew Odhiambo Fredrick C F Otieno Simon Harrison Matilda Ong'ondi Source Type: research
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
CONCLUSION: A practical approach to investigating patients with persistent thrombocytosis based on clinical characteristics such as active malignancy, chronic inflammatory disease, splenectomy, and iron deficiency may assist in accurately identifying patients more likely to have secondary causes of thrombocytosis and reduce overinvestigation, particularly costly molecular testing.PMID:38375212 | PMC:PMC10876298 | DOI:10.1155/2024/3056216 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Ala Almanaseer Benjamin Chin-Yee Jenny Ho Alejandro Lazo-Langner Laila Schenkel Pratibha Bhai Bekim Sadikovic Ian H Chin-Yee Cyrus C Hsia Source Type: research
Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review
CONCLUSIONS: MM in KNH is a disease of the middle aged, affecting men and women almost equally and presenting mainly with bone pain and anaemia. Although there seems to be a general improvement in diagnosis and care, access to novel and less toxic agents for treatment is still wanting.PMID:38375211 | PMC:PMC10876299 | DOI:10.1155/2024/3208717 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Wanjiku Gichuru Nicholas A O Abinya Andrew Odhiambo Fredrick C F Otieno Simon Harrison Matilda Ong'ondi Source Type: research
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
CONCLUSION: A practical approach to investigating patients with persistent thrombocytosis based on clinical characteristics such as active malignancy, chronic inflammatory disease, splenectomy, and iron deficiency may assist in accurately identifying patients more likely to have secondary causes of thrombocytosis and reduce overinvestigation, particularly costly molecular testing.PMID:38375212 | PMC:PMC10876298 | DOI:10.1155/2024/3056216 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Ala Almanaseer Benjamin Chin-Yee Jenny Ho Alejandro Lazo-Langner Laila Schenkel Pratibha Bhai Bekim Sadikovic Ian H Chin-Yee Cyrus C Hsia Source Type: research
Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review
CONCLUSIONS: MM in KNH is a disease of the middle aged, affecting men and women almost equally and presenting mainly with bone pain and anaemia. Although there seems to be a general improvement in diagnosis and care, access to novel and less toxic agents for treatment is still wanting.PMID:38375211 | PMC:PMC10876299 | DOI:10.1155/2024/3208717 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Wanjiku Gichuru Nicholas A O Abinya Andrew Odhiambo Fredrick C F Otieno Simon Harrison Matilda Ong'ondi Source Type: research
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
CONCLUSION: A practical approach to investigating patients with persistent thrombocytosis based on clinical characteristics such as active malignancy, chronic inflammatory disease, splenectomy, and iron deficiency may assist in accurately identifying patients more likely to have secondary causes of thrombocytosis and reduce overinvestigation, particularly costly molecular testing.PMID:38375212 | PMC:PMC10876298 | DOI:10.1155/2024/3056216 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Ala Almanaseer Benjamin Chin-Yee Jenny Ho Alejandro Lazo-Langner Laila Schenkel Pratibha Bhai Bekim Sadikovic Ian H Chin-Yee Cyrus C Hsia Source Type: research
Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review
CONCLUSIONS: MM in KNH is a disease of the middle aged, affecting men and women almost equally and presenting mainly with bone pain and anaemia. Although there seems to be a general improvement in diagnosis and care, access to novel and less toxic agents for treatment is still wanting.PMID:38375211 | PMC:PMC10876299 | DOI:10.1155/2024/3208717 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Wanjiku Gichuru Nicholas A O Abinya Andrew Odhiambo Fredrick C F Otieno Simon Harrison Matilda Ong'ondi Source Type: research
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
CONCLUSION: A practical approach to investigating patients with persistent thrombocytosis based on clinical characteristics such as active malignancy, chronic inflammatory disease, splenectomy, and iron deficiency may assist in accurately identifying patients more likely to have secondary causes of thrombocytosis and reduce overinvestigation, particularly costly molecular testing.PMID:38375212 | PMC:PMC10876298 | DOI:10.1155/2024/3056216 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Ala Almanaseer Benjamin Chin-Yee Jenny Ho Alejandro Lazo-Langner Laila Schenkel Pratibha Bhai Bekim Sadikovic Ian H Chin-Yee Cyrus C Hsia Source Type: research
Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review
CONCLUSIONS: MM in KNH is a disease of the middle aged, affecting men and women almost equally and presenting mainly with bone pain and anaemia. Although there seems to be a general improvement in diagnosis and care, access to novel and less toxic agents for treatment is still wanting.PMID:38375211 | PMC:PMC10876299 | DOI:10.1155/2024/3208717 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Wanjiku Gichuru Nicholas A O Abinya Andrew Odhiambo Fredrick C F Otieno Simon Harrison Matilda Ong'ondi Source Type: research
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
CONCLUSION: A practical approach to investigating patients with persistent thrombocytosis based on clinical characteristics such as active malignancy, chronic inflammatory disease, splenectomy, and iron deficiency may assist in accurately identifying patients more likely to have secondary causes of thrombocytosis and reduce overinvestigation, particularly costly molecular testing.PMID:38375212 | PMC:PMC10876298 | DOI:10.1155/2024/3056216 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Ala Almanaseer Benjamin Chin-Yee Jenny Ho Alejandro Lazo-Langner Laila Schenkel Pratibha Bhai Bekim Sadikovic Ian H Chin-Yee Cyrus C Hsia Source Type: research
Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review
CONCLUSIONS: MM in KNH is a disease of the middle aged, affecting men and women almost equally and presenting mainly with bone pain and anaemia. Although there seems to be a general improvement in diagnosis and care, access to novel and less toxic agents for treatment is still wanting.PMID:38375211 | PMC:PMC10876299 | DOI:10.1155/2024/3208717 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Wanjiku Gichuru Nicholas A O Abinya Andrew Odhiambo Fredrick C F Otieno Simon Harrison Matilda Ong'ondi Source Type: research
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
CONCLUSION: A practical approach to investigating patients with persistent thrombocytosis based on clinical characteristics such as active malignancy, chronic inflammatory disease, splenectomy, and iron deficiency may assist in accurately identifying patients more likely to have secondary causes of thrombocytosis and reduce overinvestigation, particularly costly molecular testing.PMID:38375212 | PMC:PMC10876298 | DOI:10.1155/2024/3056216 (Source: Advances in Hematology)
Source: Advances in Hematology - February 20, 2024 Category: Hematology Authors: Ala Almanaseer Benjamin Chin-Yee Jenny Ho Alejandro Lazo-Langner Laila Schenkel Pratibha Bhai Bekim Sadikovic Ian H Chin-Yee Cyrus C Hsia Source Type: research
Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia
Adv Hematol. 2024 Feb 8;2024:9591497. doi: 10.1155/2024/9591497. eCollection 2024.ABSTRACTChronic kidney disease (CKD) is an important risk factor for cardiovascular disease, thrombosis, and all-cause death. However, few studies have examined the association between CKD and the prognosis of patients with essential thrombocythemia (ET). We collected ET patients who met the WHO classification 2017 and performed a retrospective clinical study to clarify the association between the presence and onset of CKD and prognosis. Of 73 patients who met the diagnostic criteria, 21 (28.8%) had CKD at the time of ET diagnosis. The age of...
Source: Advances in Hematology - February 16, 2024 Category: Hematology Authors: Yoshinori Hashimoto Hiromi Omura Takayuki Tanaka Source Type: research
